Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05522231
What this trial is testing

Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2)

Who this might be right for
Advanced Renal Cell Carcinoma
Hutchmed 265
Not applicableStudy completedNCT01236053
What this trial is testing

Cancer in Patients With Gabapentin (GPRD)

Who this might be right for
Pain, NeuropathicEpilepsyRenal Pelvis Cancer+13 more
GlaxoSmithKline 2,323,608
Testing effectiveness (Phase 2)UnknownNCT02613819
What this trial is testing

Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney

Who this might be right for
Renal Cell Carcinoma
Trans Tasman Radiation Oncology Group 71
Early research (Phase 1)Study completedNCT00096629
What this trial is testing

Vaccine Therapy in Treating Patients With Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center 15
Early research (Phase 1)Ended earlyNCT04187872
What this trial is testing

LITT and Pembrolizumab in Recurrent Brain Metastasis

Who this might be right for
MelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)+12 more
University of Florida 10
Early research (Phase 1)Active Not RecruitingNCT03872947
What this trial is testing

TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorColorectal CancerCholangiocarcinoma+9 more
Toray Industries, Inc 138
Large-scale testing (Phase 3)Looking for participantsNCT06467097
What this trial is testing

Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma

Who this might be right for
Kidney Neoplasm
Samsung Medical Center 88
Not applicableStudy completedNCT01138124
What this trial is testing

Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)

Who this might be right for
Renal Pelvis CancerRestless Legs SyndromeEpilepsy+7 more
GlaxoSmithKline 54,202
Testing effectiveness (Phase 2)UnknownNCT00717587
What this trial is testing

Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer

Who this might be right for
Kidney Cancer
Abramson Cancer Center at Penn Medicine 20
Testing effectiveness (Phase 2)UnknownNCT03047525
What this trial is testing

Study of DC-CTL Combined With CIK for Advanced Solid Tumor

Who this might be right for
Colorectal CancerRenal Cell CarcinomaNasopharyngeal Carcinoma+1 more
Xiaoyi Huang 200
Not applicableLooking for participantsNCT03981497
What this trial is testing

Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms

Who this might be right for
Liver CancerLiver Metastasis Colon CancerKidney Cancer+1 more
Francesco De Cobelli 500
Testing effectiveness (Phase 2)WithdrawnNCT05176288
What this trial is testing

Avelumab, Palbociclib and Axitinib in Advanced RCC

Who this might be right for
Advanced Clear Cell Renal Cell Carcinoma
Bradley A. McGregor, MD
Early research (Phase 1)Study completedNCT03319459
What this trial is testing

FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors

Who this might be right for
HER2 Positive Gastric CancerColorectal CancerHead and Neck Squamous Cell Carcinoma+8 more
Fate Therapeutics 44
Not applicableStudy completedNCT04416646
What this trial is testing

Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Istituto Oncologico Veneto IRCCS 100
Not applicableStudy completedNCT04960059
What this trial is testing

NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts

Who this might be right for
CancerMetastatic MelanomaRenal Cell Carcinoma+1 more
The Christie NHS Foundation Trust 24
Testing effectiveness (Phase 2)Looking for participantsNCT06601296
What this trial is testing

Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma ( mRCC)OligoProgressive Metastatic Disease
University of Texas Southwestern Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT01884961
What this trial is testing

Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-dose Interleukin-2

Who this might be right for
Metastatic Renal Cell CancerMalignant Melanoma, Metastatic
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 46
Not applicableStudy completedNCT07117786
What this trial is testing

Computed Tomography Radiomics-Derived Nomogram for Predicting Early Renal Function Decline After Partial Nephrectomy in Renal Cell Carcinoma: A Multicenter Development/Validation Study

Who this might be right for
Renal Cell Carcinoma (RCC)
First Affiliated Hospital of Fujian Medical University 1,437
Large-scale testing (Phase 3)Study completedNCT01613846
What this trial is testing

Phase III Sequential Open-label Study to Evaluate the Efficacy and Safety of Sorafenib Followed by Pazopanib Versus Pazopanib Followed by Sorafenib in the Treatment of Advanced / Metastatic Renal Cell Carcinoma (SWITCH-II)

Who this might be right for
Renal Cell Carcinoma
Technical University of Munich 544
Not applicableUnknownNCT05816642
What this trial is testing

Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
RenJi Hospital 500
Next Page